Aster DM Healthcare Rises After Acquiring 5% Stake in Quality Care India Ahead of Strategic Merger

Mumbai, India May 2, 2025: Aster DM Healthcare Ltd witnessed a modest rise in its share price following the completion of its acquisition of a 5% stake in Quality Care India Ltd (QCIL). This move marks the initial step in the much-anticipated strategic merger between the two healthcare giants.

Stock Performance Reflects Positive Market Sentiment

Aster DM Healthcare’s shares were trading at Rs. 506.30, up by Rs. 1.30 or 0.26% from the previous close of Rs. 505.00 on the Bombay Stock Exchange (BSE). The stock opened at Rs. 503.55, touching an intraday high of Rs. 509.70 and a low of Rs. 497.15. A total of 5,617 shares were traded during the session.

The company, listed under BSE’s Group ‘A’, has a current market capitalization of Rs. 24,868.26 crore. Over the last 52 weeks, the stock has fluctuated between a high of Rs. 534.00 (recorded on January 7, 2025) and a low of Rs. 312.25 (on June 4, 2024). In the past week alone, it ranged from Rs. 519.55 to Rs. 492.70.

Acquisition Marks Strategic Merger Milestone

Aster DM Healthcare completed the Rs. 849 crore acquisition from BCP Asia II TopCo IV (BCP) and Centella Mauritius Holdings (Centella) via a share swap agreement. The transaction signifies a key milestone in the integration of Quality Care India Ltd (QCIL) with Aster DM Healthcare, a strategic merger first announced in November 2024.

The acquisition aligns with Aster’s long-term vision to create a unified, future-ready healthcare network in India. By initiating the merger process with this stake acquisition, Aster aims to fortify its operational scale and geographic footprint across the country.

Strengthening India’s Healthcare Infrastructure

Aster DM Healthcare is recognized for its diversified presence across the healthcare value chain, including hospitals, clinics, and retail pharmacies. The company operates under established brands such as Aster, Medcare, and Access, delivering services to a broad socio-economic spectrum in India and the GCC (Gulf Cooperation Council) states.

The upcoming merger with QCIL is expected to significantly enhance Aster’s capabilities, providing seamless access to quality healthcare across a wider regional network and positioning the company for continued growth in a rapidly evolving industry.